High assay low enriched uranium (haleu) cascade demo completion and extended production

Ended Definitive Contract Awarded Last action

Contract number
89243223CNE000030
Awardee
Awarding agency
Obligated
$317,041,412

Award facts

Opportunity
Contract value 29% obligated
  • $332,420,137.11 Current, with exercised options
  • $1,111,105,513.50 Potential, with all options
Completion date 100% complete
  • Current, with exercised options
  • Potential, with all options
Funding agency
Office of Nuclear Energy Department of Energy
PSC
4470 Nuclear Reactors
Set-aside
No set-aside
Competition
Full and Open Competition · 2 offers Negotiated Proposal / Quote
Pricing
Cost Sharing
Place of performance
Piketon, OH 45661, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Change Order P00028 · The purpose of this amendment is to: 1. Extend option period 1B 15 days 2. Authorize change orders under clin 0006 $0
Change Order P00025 · The purpose of this amendment to the contract is to extend the phase 2 period of performance from october 31, 2025, to january 31, 2026. $0
Change Order P00024 · The purpose of this amendment to the contract is to authorize multiple change orders, approve a new CBA agreement, and extend the phase 2 period of performance. $1,556,984
Funding Only Action P00023 · Incrementally fund clin 0002 in the amount of $11,049.88. Incrementally fund clin 0003 in the amount of $107,993,746.00. $108,004,796
Exercise an Option P00022 · Modify and exercise option period by splitting IT up between two clins, from a 3-year option period under one clin to a one and two-year option period under two… $0
Funding Only Action P00021 · Authorize moving scope from clin 003 to clin 002 to purchase the LEU feed cylinder they need for phase 3 production in november 2025, procuring additional waste… $8,238,455
Funding Only Action P00020 · 1. Authorize continued performance of phase 2 activities through june 30, 2025, and authorize limited funding in the amount of $8,530,292.00 2. Provide… $8,530,292
Other Administrative Action P00019 · 1. Authorize continued performance of phase 2 activities through may 31, 2025. 2.provide incremental funding under clin 0002 in the amount of $7,600,000,… $7,600,000
Other Administrative Action P00018 · The purpose of this amendment to the contract is to: 1.extend the definitization deadline detailed in modification 017 of this contract from march 31, 2025 to… $15,694,008
Other Administrative Action P00017 · 1.extend the definitization deadline detailed in modification 015 of this contract from february 28, 2025, to march 31, 2025. 2.authorize continued… $0
Funding Only Action P00016 · The purpose of this modification is to: 1. Provide incremental funding to clin 0002 in the amount of $14,211,340.00, changing the total obligation from… $14,211,340
Other Administrative Action P00015 · The purpose of this modification is to: extend the definitization deadline detailed in modification 013 of this contract from december 31, 2024, to february 28,… $0
Change Order P00014 · The purpose of this modification is to add incremental funding and approve four change orders $9,875,250
Change Order P00013 · 1.extend the phase 2 period of performance end date from november 6, 2024, to june 30, 2025 $24,105,027
Definitize Change Order P00012 · The purpose of this amendment to: 1. Authorize the purchase and installation of two replacement personnel contamination monitors(pcms) 2. Authorize the purchase… $0
Change Order P00011 · The purpose of this amendment to: 1.provide incremental funding to clin 0002 in the amount of $28,906,490.90 2.provide incremental funding to clin 0006 in the… $29,252,012
Funding Only Action P00010 · The purpose of this amendment to the contract is to: 1. DE-obligate clin 0002 funding in the amount of -$5,463,616.00 in order to complete the internal DOE… -$5,463,616
Funding Only Action P00009 · 1. Provide incremental funding to clin 0002 in the amount of $20,627,096.00, changing the total obligation from $39,080,875.23 to $59,707,971.23. Note: a… $20,627,096
Funding Only Action P00008 · Provide incremental funding to clin 0002 in the amount of $9,799,429.60, changing the total obligation from $29,281,445.63 to 39,080,875.23. $9,799,430
Funding Only Action P00007 · Provide incremental funding to clin 0002 in the amount of $4,756,181.53, changing the total obligation from $24,525,264.10 to $29,281,445.63. $4,756,182
Funding Only Action P00006 · 1.obligate funding to clin 0001 for $770,016.87.00, changing the total obligation from $28,270,000.00 to $29,040,016.87. 2.obligate funding to clin 0007 for… $20,565,281
Funding Only Action P00005 · 1) obligate $901,128.00 to clin 00006, changing the total obligation from $150,000.00 to $1,051,128.00. 2) obligate $4,562,488.00 to clin 00007, changing the… $5,463,616
Definitize Change Order P00004 $350,000
Funding Only Action P00003 $23,000,000
Other Administrative Action P00002 · 1.incremental funding in the amount of $5,000,000. 2.update the period of performance start from 11/30/22 to 12/01/22. 3.update clause 52.244-2 subcontracts… $5,000,000
Other Administrative Action P00001 $2,796,121
Original award $2,203,879
Show all 27

About this award

Written by GovTribe AI ·

The Department of Energy's Office of Nuclear Energy awarded a $1.11 billion definitive contract to American Centrifuge Operating, LLC for high-assay low-enriched uranium (HALEU) cascade demonstration completion and extended production on November 30, 2022, under cost-sharing pricing with no set-aside.

The originating solicitation, posted as a total small business set-aside in February 2022, required completion of a 16-centrifuge demonstration cascade at the Piketon, Ohio facility, operational demonstration of annual HALEU production of at least 900 kilograms at 19.75% U-235 enrichment, and collection of operational performance data. The current contractor had completed 84% of cascade demonstration work at the time of solicitation. Place of performance is Piketon, OH. The contract ceiling is $1.11 billion with an ultimate completion date of June 30, 2028. An amendment to this contract extends Option Period 1B by 15 days and authorizes change orders under CLIN 0006.

Quick answers

Who was awarded contract 89243223CNE000030?

89243223CNE000030 was awarded to American Centrifuge Operating, LLC by National Nuclear Security Administration (Department of Energy) on November 30, 2022.

How much is contract 89243223CNE000030 worth?

The government has obligated $317,041,412 on 89243223CNE000030. Its current value, with exercised options, is $332,420,137. Its potential value, with all options, is $1,111,105,514.

Which agency awarded contract 89243223CNE000030?

National Nuclear Security Administration (Department of Energy) awarded 89243223CNE000030, with funding from Office of Nuclear Energy (Department of Energy).

Was contract 89243223CNE000030 competed?

The extent of competition for 89243223CNE000030 was full and open competition. The government received 2 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login